So far, two anti-KIT ADCs (LOP628-DM1 and NN2101-DM1) [248–250] and one anti-GPR20 ADC (DS-6157a) [251, 252] have been developed and tested in GIST. Here, GPR20 is linked to gastrointestinal stromal tumor.